This is a working overview of acetylated peptide, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-11-04 and is reviewed periodically as new material appears.
Material sold under this label typically arrives as a freeze-dried powder in a sealed vial with a certificate of analysis. Such certificates usually report reversed-phase chromatography purity plus a mass confirmation, and stated purities commonly sit between 95 and 99 percent. Counter-ion identity, residual trifluoroacetate, water content, and peptide net weight are separate specifications that a certificate may or may not include. A purity figure alone does not establish sequence identity, so independent mass verification remains the practical check.
The designation TB-500 circulates in laboratory and catalog contexts without a single agreed definition. Most product listings apply it to an N-terminally acetylated seven-residue fragment of thymosin beta-4, while other listings attach the same label to the full 43-residue protein. Because the term is commercial rather than systematic, two entries bearing identical names may describe different molecules. Any documentation should therefore state which sequence a given sample is claimed to contain.
The fragment most often associated with the name carries the sequence Ac-LKKTETQ, matching residues 17 through 23 of thymosin beta-4. That region holds the actin-binding motif responsible for much of the parent protein's biochemical activity. Apart from N-terminal acetylation the peptide is unmodified and contains no disulfide bonds, so it shows little ordered secondary structure in solution. Full-length thymosin beta-4 is instead a 43-residue polypeptide of roughly 4.9 kDa found widely across mammalian cell types.
Thymosin beta-4 contains 43 amino acids and has a reported molecular mass near 4963 Da. The short fragment most often associated with the TB-500 label, an acetylated chain beginning LKKTETQ, has a reported mass near 889 Da, so the two are easily separated in analytical work. Mass spectrometry and amino acid analysis can confirm which material is present in a given sample. Statements treating TB-500 and thymosin beta-4 as interchangeable are therefore imprecise, even though the two appear together in much of the same literature.
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | ≈889 Da for the 7-residue fragment | Full-length thymosin beta-4 is ≈4.9 kDa; catalogs differ |
| Appearance | White to off-white powder | Hygroscopic; weight shifts with residual moisture |
| Solubility class | Freely soluble in water | Also dissolves in aqueous buffers; poorly soluble in nonpolar solvents |
| Typical storage temperature | −20 °C, desiccated, protected from light | Once rehydrated, short-term holding at 2-8 °C |
| Typical analytical method | Reversed-phase HPLC with mass spectrometry | Purity by UV absorbance; identity by ESI-MS or MALDI-TOF |
TB-500 is a research peptide whose sequence matches residues 17 to 23 of thymosin beta-4, a 43-residue protein present in most mammalian cells. The chain is seven amino acids long, written as LKKTETQ, and is normally supplied with an acetyl group on the N-terminus. Suppliers list it as a lyophilised powder under the code name TB-500, and the same sequence appears elsewhere in catalogues as the thymosin beta-4 actin-binding fragment. The label is commercial rather than systematic, so no single authority fixes exactly what TB-500 denotes.
Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.
Dry peptide powder is commonly kept at −20 °C in a desiccated container away from light, a practice that limits moisture uptake and oxidation. Once dissolved, solutions are generally held at 2–8 °C for short periods or frozen at −20 °C or lower for longer storage, with repeated freeze-thaw cycles avoided. Hydrolysis and oxidation are the main degradation routes for peptides in solution, and both accelerate at higher temperature or extreme pH. Published stability data specific to TB-500 are limited, so shelf life should be treated as uncertain.
Identity and purity checks for peptide material typically combine reversed-phase high-performance liquid chromatography with mass measurement, since retention time alone cannot confirm a sequence. Mass measurement verifies the expected molecular mass within instrument tolerance, while chromatographic peak area provides a purity estimate. Anti-doping analysis of urine uses related but more sensitive workflows, sometimes after solid-phase extraction. For research material, batch documentation, certificate content, and independent testing are common points of scrutiny, because supply chains outside pharmaceutical regulation vary widely in the paperwork they provide.
Reconstitution of a lyophilized peptide is normally done with sterile water or a suitable buffer under aseptic conditions. Adding solvent down the vial wall and allowing gentle dissolution instead of vigorous vortexing reduces the chance of aggregation, which can lower the effective concentration of the resulting solution. Concentrated stocks are usually diluted into working buffer shortly before use. Because no standard preparation protocol exists for TB-500 specifically, laboratories adapt general peptide handling practice, and reported results may reflect differing preparation choices.
In 1998, at the 5th Conference of the Inter‑American Masonic Confederation (CMI) (Spanish: Confederación Masónica Interamericana), the 95 member bodies of CMI recognized the Grand Lodge of Cuba as "regular and correct," and rejected the regularity claims of the Grand Lodge of Cuba in Exile. In 2000, the Cuban government pressured the Grand Lodge of Cuba to elect a man named José Manuel Collera Venta as Grand Master. In 2005, when the Grand Lodge of Cuba attempted to expel Venta from Freemasonry "for an undisclosed reason," the Cuban government again intervened and stopped that from happening. By May 8, 2000, two factions existed within Cuban Freemasonry. One faction based in the National Temple headquarters preferred not to display any dissent against the government for the fear that their Lodges would be shuttered, but another faction within the leadership of the local Lodges advocated that Freemasons should be faithful to their statues, maintaining an impartial political position, no matter the consequences that might befall them. Lodges further away from Havana had more freedom due to less infiltration by government agents. In 2002, the Grand Lodge of Cuba reestablished its relationship with the Grand Lodge of Italy and the Grand Orient of Italy. By the year 2008, there were 29,110 Freemasons in Cuba, compared to 1980, when there were only 19,690.
== Jung's wound == Scholars suggest that Jung's childhood vulnerabilities compelled him to heal his own life. Jung stated that "certain psychic disturbances can be extremely infectious if the doctor himself has a latent predisposition in that direction...For this reason he runs a risk - and must run it in the nature of things". Further he stated that "it is no loss, either, if [the analyst] feels that the patient is hitting him, or even scoring off him: it is his own hurt that gives the measure of his power to heal". Jungians acknowledge that Jung's own wounds could cause damage to those he was attempting to heal.
The establishment is a modern, structured research institute composed of six laboratories dedicated to Virology, Parasitology, Bacteriology, Medical Entomology, Clinical Biology and Pathology, including a Research Center for animals and a data center. Each laboratory is made up of a dedicated director and staff, including students and international collaborators. Each laboratory has the basic equipment and the space necessary for optimal research. It is available to faculty, students, post-docs and staff from the periphery of the INRB. Due to the structure of the INRB, if sharing and access to individual laboratory equipment is required, access is granted at the request and approval of the directors of these laboratories. The INRB common area includes some major equipment. All collaborators and researchers have, upon request, access to several -80 freezers, liquid nitrogen tanks, centrifuges, water baths, tissue homogenizers, vortexes, incubators, agitators, and all laboratories have access to cold chain equipment such as dry shippers and portable freezers. The INRB was founded in 1984 and has been a World Health Organization collaborating centre since 2018. The INRB and the World Health Organization have worked closely together on research into the effectiveness of the ring vaccination strategy during the 2018 Kivu Ebola outbreak. The National Biomedical Research Institute (INRB) has eight dynamic departments, which participate in the institute's various missions, namely monitoring, research, and training.
=== Oxidative stress === Numerous whole-exome sequencing studies have demonstrated that vitiligo is associated with polymorphisms in genes involved in the response to oxidative stress, supporting the association of elevated levels of reactive oxygen species in melanocytes with the induction of an autoimmune response. Thus, diseases presenting with altered mitochondrial function such as MELAS, Vogt–Koyanagi–Harada and Kabuki syndrome are associated with an increased risk of vitiligo. In line with these observations, genetic alterations in mitochondrial DNA (mtDNA) of melanocytes associated with altered mitochondrial function lead to a release of mtDNA that can be detected in the skin of vitiligo patients. This mtDNA can be sensed by the cGAS–STING pathway, resulting in pro-inflammatory cytokine and chemokine production promoting the recruitment of cytotoxic T cells.
Sources: en.wikipedia.org
Nicotinamide, as a part of the cofactor nicotinamide adenine dinucleotide (NADH / NAD+), is crucial to life. In cells, nicotinamide is incorporated into NAD+ and nicotinamide adenine dinucleotide phosphate (NADP+). NAD+ and NADP+ are cofactors in a wide variety of enzymatic oxidation-reduction reactions, most notably glycolysis, the citric acid cycle, and the electron transport chain. If humans ingest nicotinamide, it will likely undergo a series of reactions that transform it into NAD, which can then undergo a transformation to form NADP+. This method of creation of NAD+ is called a salvage pathway. However, the human body can produce NAD+ from the amino acid tryptophan and niacin without ingestion of nicotinamide. NAD+ acts as an electron carrier that mediates the interconversion of energy between nutrients and the cell's energy currency, adenosine triphosphate (ATP). In oxidation-reduction reactions, the active part of the cofactor is the nicotinamide. In NAD+, the nitrogen in the aromatic nicotinamide ring is covalently bonded to adenine dinucleotide. The shared electrons of the other carbon atoms in the aromatic ring stabilize the formal charge on the nitrogen. When a hydride atom is added onto NAD+ to form NADH, the molecule loses its aromaticity and therefore a good amount of stability. This higher-energy product later releases its energy by donating a hydride, and in the case of the electron transport chain, it assists in forming adenosine triphosphate. When one mole of NADH is oxidized, it releases 158.2 kJ of energy.
The rate of vegetarianism by country varies substantially from relatively low levels in countries such as the Netherlands (5%) to more considerable levels in India (20–40%). Estimates for the number of vegetarians per country can be subject to methodological difficulties, as respondents may identify as vegetarian even if they include some meat in their diet, and thus some researchers suggest the percentage of vegetarians may be significantly overestimated.
=== Charged Lemonade lawsuits === On September 10, 2022, 21-year-old Sarah Katz, a student at the University of Pennsylvania, purchased and consumed a "supercharged" lemonade drink from a Panera location in Philadelphia. Allegedly, Katz was unaware of the high caffeine content of the drinks, which has been criticized as extremely dangerous; a 20-US-fluid-ounce (590 ml) Panera Charged Lemonade contained 260 mg of caffeine, equivalent to four espresso shots, and the 30-ounce (890 mL) lemonade contained 390 mg (six espressos). Katz suffered from Long QT Type 1 Syndrome, a heart condition that can result in an irregular heartbeat in certain situations. On the same day, Katz went into cardiac arrest while at another restaurant and was transported to the Pennsylvania Presbyterian Hospital, where she suffered another arrest and was then pronounced dead. In October 2023, Katz's parents sued Panera for the wrongful death of their daughter caused by misleading labeling and description of the drink. Later in October, amid reports that dispensers had been moved behind the counter to limit access, Panera changed labeling for the drink, noting its caffeine content and need for moderation, and warning potentially sensitive consumers. In December 2023, a second individual was reported as having died after consuming Panera's Charged Lemonade. The individual, Dennis Brown, died at age 46 after reportedly consuming three servings of Charged Lemonade at a Panera location in Fleming Island, Florida.
Sources: en.wikipedia.org
Usually not, though usage overlaps. The label most often refers to a short acetylated fragment of the parent protein, while thymosin beta-4 itself is the full 43-residue molecule. Because suppliers vary, a sequence statement is needed to settle the question for any particular lot.
The name is a commercial label rather than a systematic chemical designation, so different vendors and papers attach it to different sequences. Some treat it as a fragment and others as the whole protein. Comparing two reports therefore requires checking what each one actually analyzed.
Typically it reflects the relative area of the main peak in a reversed-phase chromatogram at a given wavelength. It does not confirm the amino acid sequence, the counter-ion, or the amount of peptide by mass. Identity is normally established by a separate mass measurement.
No. TB-500 is a trade-style label used for a synthetic peptide described as a fragment of thymosin beta-4, while thymosin beta-4 is the full 43-residue protein. The two differ in size and are not interchangeable terms in analytical work.